Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06614114

Enrollment

Registered

2024-09-26

Start date

2024-09-24

Completion date

2025-12-01

Last updated

2024-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediction of Variceal Bleeding

Brief summary

Albumin bilirubin index as a predictor of outcome of variceal bleeding

Detailed description

This study is to clarify the predictive value of albumin bilirubin index for recurrent bleeding within 3 month after endoscopic treatment in patients with cirrhosis and EGVB

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Inclusion criteria

* age between 18-80 years old

Exclusion criteria

* Hcc Hematological disease

Design outcomes

Primary

Measure	Time frame	Description
prevelence of Variceal bleeding in high alb/bill index	6 months	Prevelence of bleeding in patient with cirrhosis

Countries

Egypt

Contacts

Primary ContactHeba Sayed Zaki

hoopa.1996@gmail.com0201148259100

Backup ContactAhmed M.Ashmawy

dr.Ashmawy82@gmail.com01005679880

Outcome results